Tdap in Pregnancy

Tdap vaccination during each pregnancy protects the newborn from pertussis (whooping cough) through transplacental transfer of maternal antibodies. Newborns are most vulnerable to pertussis before they can be vaccinated at 6 weeks. India's IAP and global health bodies recommend Tdap in every pregnancy regardless of prior Tdap history.

The Tdap in Pregnancy is recommended for Pregnant women at 27-36 weeks with each pregnancy. It falls under the Women's Health vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Tdap in Pregnancy has an efficacy of 91% protection against pertussis in infants < 2 months of age whose mothers were vaccinated. This means it provides significant protection against Pertussis (Whooping Cough) in newborns and Neonatal tetanus. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Injection site pain (very common); headache; fatigue; myalgia. No increased risk of adverse pregnancy outcomes. Not associated with preterm labour. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Tdap in Pregnancy should be avoided by: Severe allergic reaction to prior Tdap dose or any component. Encephalopathy within 7 days of prior pertussis-containing vaccine. Prior Arthus-type hypersensitivity to tetanus or diphtheria toxoid.. Always inform your healthcare provider of your full medical history before vaccination.

The Tdap in Pregnancy typically costs ₹600–₹1,200 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.